Lederle Pharma Limited
Pharmaceutical company that manufactures, trades, and exports various veterinary and pharmaceutical products.
2007 | Delhi (India) | Active
Lederle Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 Cr
- Revenue Growth 34.26%
- Profit Growth 115.56%
- Ebitda 125.41%
- Net Worth 0.50%
- Total Assets 57.58%
About Lederle Pharma
Lederle Pharma Limited (LPL) is a Public Limited Indian Non-Government Company incorporated in India on 14 September 2007 and has a history of 17 years and five months. Its registered office is in Delhi, India.
The Corporate was formerly known as Lederle Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹1.25 Cr.
Sanjay Surana, Mehul Surana, and Ajay Surana serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233DL2007PLC168221
- Company No.
168221
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Lederle Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Surana  | Director | 26-Oct-2007 | Current |
| Mehul Surana | Director | 12-Jul-2021 | Current |
| Ajay Surana | Director | 01-Jul-2017 | Current |
Financial Performance of Lederle Pharma.
Lederle Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.26% increase. The company also saw a substantial improvement in profitability, with a 115.56% increase in profit. The company's net worth moved up by a moderate rise of 0.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lederle Pharma?
In 2022, Lederle Pharma had a promoter holding of 35.18% and a public holding of 64.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jas Leasing And Property Developers Limited.
Sanjay Surana and Ajay Surana are mutual person
- La Teste Lab Private Limited
Sanjay Surana is a mutual person
- Surana Buildcon Private Limited
Sanjay Surana and Mehul Surana are mutual person
- Surana Buildwell Private Limited
Mehul Surana is a mutual person
- Nuvilife Global Llp
Ajay Surana is a mutual person
- Eastern Capulations Private Limited
Ajay Surana is a mutual person
Charges (Loans)
Open Charges
₹1.25 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- The Nainital Bank Limited : 1.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2010 | The Nainital Bank Limited | ₹1.25 Cr | Open |
How Many Employees Work at Lederle Pharma?
Unlock and access historical data on people associated with Lederle Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lederle Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lederle Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Lederle Pharma
Recent activity within the organization
- Annual General Meeting
Lederle Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Lederle Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Mehul Surana was appointed as a Director was appointed as a Director on 12 Jul 2021 & has been associated with this company since 3 years 7 months .
- Director Appointment
Ajay Kumar Surana was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 7 years 8 months .
- Charges
A charge with The Nainital Bank Limited amounted to Rs. 1.25 Cr with Charge ID 10225664 was registered on 14 Jun 2010.
- Director Appointment
Sanjay Surana was appointed as a Director was appointed as a Director on 26 Oct 2007 & has been associated with this company since 17 years 4 months .
Frequently asked questions
What is the Incorporation or founding date of Lederle Pharma Limited?
Lederle Pharma Limited was incorporated on 14 Sep 2007.
What is authorized share capital and paid-up capital of Lederle Pharma Limited?
The authorized share capital of Lederle Pharma Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.25 Cr.
Who are the current board members & directors of Lederle Pharma Limited?
Currently 3 directors are associated with Lederle Pharma Limited.
- Sanjay Surana
- Mehul Surana
- Ajay Kumar Surana
What is the registered address of Lederle Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Lederle Pharma Limited is A-75 Second Floor Block - A Kirti Nagar, India, Delhi, 110015.
What is the corporate identification number (CIN) and company number of Lederle Pharma Limited?
The corporate identification number (CIN) of Lederle Pharma Limited is U24233DL2007PLC168221 and the company number is 168221 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Lederle Pharma Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Lederle Pharma Limited has risen by 34.26%.
What change has been observed in the net worth of Lederle Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Lederle Pharma Limited has experienced an upsurge of 0.50%.
What are the total open charges for Lederle Pharma Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Lederle Pharma Limited amount to ₹ 1.25 Cr.
When was the last Balance Sheet of Lederle Pharma Limited filed with the ROC?
The most recent Balance Sheet for Lederle Pharma Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Deepanjay JainDirectorSS
Suraj SuranaAdditional DirectorUS
Urmila SuranaAdditional DirectorRS
Rajesh SharmaManaging DirectorMS
Mahima SharmaDirectorRH
Rakesh HandaDirectorDG
Deepak GoswamiDirectorSS
Sushma SharmaDirector